Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Neurobiol Aging. 2009 Mar 28;32(2):223–234. doi: 10.1016/j.neurobiolaging.2009.02.011

Table 1.

Case list

Group Case Δ Age(y) Sex § PMI(h) Braak Stage * ApoE
ND Human E04-46 40 m 31 Braak 0 3/4
E04-34 57 f 17 Braak 0 3/3
OS02-35 75 f 6 Braak 0 3/3
Human AD E04-33 57 f 20 Braak V/VI 3/4
E04-172 87 f 6 Braak V/VI 3/4
OS03-300 75 f 12 Braak V/VI 4/4
OS02-159 61 m 5.5 Braak V/VI 3/4
OS01-128 91 f 2.5 Braak V/VI 3/4
OS02-106 81 f 2 Braak >IV 3/3
E05-87 61 m 4 Braak V/VI 3/4
E08-41 84 m 4.5 Braak VI 3/4
E05-04 64 f 4.5 Braak VI 3/4
Chimpanzee YN06-108Pt 44 f 3
YN07-25Pt 47 f 1
YN05-400Pt 41 f 1
Rhesus macaque 06-1Mm 35 f <3
AM109 26.6 m 1
AM120 26.5 f 1
554 38 m <3
1201 35 m <3
1203 33 f <3
1210 30 m <3
1211 25 f <3
1313 >20 m <3
Squirrel monkey 84L 21 m 1
83GO 20 m 1
86J 17 m 1
06-5Ss 23 f <3
90T 17 m 1
92AH 15 m 1
Δ

Age (y): Age (years)

§

PMI (h): Postmortem interval (hours)

*

ApoE: Apolipoprotein E genotype

HHS Vulnerability Disclosure